Company intelligence / Profile preview

Imunoinstant

Voluntari, Ilfov, Romania
Ownership
Private
Employees
~450
Development stage
Other
01

Overview

Imunoinstant is a specialized biotechnology division of Romvac Company S.A., based in Romania, focused on the development of hyperimmune egg-based biological products. The company leverages avian IgY antibody technology to produce treatments for various human pathologies, including antibiotic-resistant bacterial infections, viral diseases, and inflammatory conditions. Their core technology involves immunizing hens against specific pathogens to produce eggs rich in targeted antibodies, which are then processed into oral solutions, topicals, and food supplements. Imunoinstant's commercial portfolio addresses indications such as Helicobacter pylori infections, psoriasis, and respiratory tract infections. By providing a passive immunity approach, the company offers an alternative or adjunct to traditional antibiotic therapies.

Therapeutic areas
Infectious DiseasesDermatologyGastroenterology
Modalities
AntibodyBiologic
Industry
Biotech

Beyond the preview

Go deeper on Imunoinstant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imunoinstant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call